Judge Rules For Abbott In Biaxin Patent Battle

Law360, New York (June 5, 2005, 12:00 AM EDT) -- A judge with a federal district court in Illinois has granted Abbott Laboratories a preliminary injunction against Teva Pharmaceutical Industries Ltd. to keep the Israeli drug maker from launching a generic extended-release version of the antibiotic Biaxin.

Judge David Coar of the U.S. District Court for the Northern District of Illinois in Chicago granted Abbott's request, in a move that could keep Teva from launching its generic version until the outcome of a patent trial, which could start late this year or early next year....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.